With a few exceptions, both IMB and LAP, especially their combinations, significantly inhibited tubular dilation, tubulointerstitial degeneration or atrophy, interstitial chronic inflammation, and acute inflammation in kidneys of the CKD mice. This evidence concerns the gene TGFB1 and chronic kidney disease.